Holger Eidtmann
Impact in
- Cancer Research top 0.05%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Bone health and treatments
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 71
- Oncology 46
- HER2/EGFR in Cancer Research 27
- Bone health and treatments 10
- Cancer Treatment and Pharmacology 3
- Neutropenia and Cancer Infections 2
- Cancer Cells and Metastasis 2
- Co-authors
- Gϋnter von Minckwitz (44 shared papers)J. Hilfrich (32 shared papers)Christian Jackisch (30 shared papers)Sibylle Loibl (36 shared papers)Jens‐Uwe Blohmer (34 shared papers)Jens Huober (27 shared papers)Serban Dan Costa (22 shared papers)Manfred Kaufmann (12 shared papers)
- Journals
- Annals of Oncology (19 papers)Journal of Clinical Oncology (14 papers)Cancer Research (7 papers)European Journal of Cancer (7 papers)Clinical Cancer Research (6 papers)
- Partner nations
- GermanyUnited StatesBelgium
In The Last Decade
Holger Eidtmann
101 papers receiving 18.2k citations
Holger Eidtmann's Hit Papers
Peers
Comparison fields: 5 of 104
- Cancer Research 10.8k
- Oncology 6.4k
- Radiology, Nuclear Medicine and Imaging 1.2k
- Orthopedics and Sports Medicine 312
- Pathology and Forensic Medicine 511
Countries citing papers authored by Holger Eidtmann
This map shows the geographic impact of Holger Eidtmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Eidtmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Eidtmann more than expected).
Fields of papers citing papers by Holger Eidtmann
This network shows the impact of papers produced by Holger Eidtmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Eidtmann. The network helps show where Holger Eidtmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Holger Eidtmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis Hit paper breakdown → | 2014 | 3695 |
| 2 | Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes Hit paper breakdown → | 2012 | 2112 |
| 3 | Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial Hit paper breakdown → | 2012 | 1099 |
| 4 | Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer Hit paper breakdown → | 2009 | 856 |
| 5 | Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial Hit paper breakdown → | 2014 | 810 |
| 6 | 2015 | 507 | |
| 7 | 2010 | 451 | |
| 8 | 2012 | 434 | |
| 9 | 2010 | 430 | |
| 10 | 2011 | 390 | |
| 11 | 2014 | 390 | |
| 12 | 2012 | 361 | |
| 13 | 2005 | 344 | |
| 14 | 2016 | 338 | |
| 15 | 2013 | 314 | |
| 16 | 2015 | 304 | |
| 17 | 2012 | 285 | |
| 18 | 2010 | 250 | |
| 19 | 2008 | 247 | |
| 20 | 2014 | 234 |
About Holger Eidtmann
Holger Eidtmann is a scholar working on Cancer Research, Oncology, Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Dermatology, having authored 105 papers that have together received 18.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (71 papers), HER2/EGFR in Cancer Research (27 papers), Bone health and treatments (10 papers), Cancer Treatment and Pharmacology (3 papers), Neutropenia and Cancer Infections (2 papers), Cancer Cells and Metastasis (2 papers), Medical Imaging Techniques and Applications (2 papers) and Chemotherapy-induced cardiotoxicity and mitigation (2 papers). The work is most often cited by research in Cancer Research (10.8k citations), Oncology (6.4k citations), Radiology, Nuclear Medicine and Imaging (1.2k citations), Orthopedics and Sports Medicine (312 citations) and Pathology and Forensic Medicine (511 citations). Holger Eidtmann has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Gϋnter von Minckwitz, J. Hilfrich, Christian Jackisch, Sibylle Loibl, Jens‐Uwe Blohmer, Jens Huober, Serban Dan Costa, Manfred Kaufmann, Michael Untch and Bernd Gerber. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Cancer Research, European Journal of Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.